Optimization of Spectroscopic Imaging Parameters and Procedures for Prostate at 3 Tesla Using an External Probe
NCT00314535 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2016-02-25
Summary
Magnetic resonance (MR) spectroscopic techniques are to be developed to obtain the best data possible at 3 Tesla (3T) for the prostate.
Conditions
- Healthy
Sponsors & Collaborators
-
Cross Cancer Institute
collaborator OTHER -
AHS Cancer Control Alberta
lead OTHER
Principal Investigators
-
Gino Fallone, PhD · AHS Cancer Control Alberta
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-07-31
- Primary Completion
- 2008-10-31
- Completion
- 2008-10-31
Countries
- Canada
Study Locations
More Related Trials
-
PSMA-PET Directed Radiation Therapy for High-Risk Prostate Cancer
NCT07291557 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort
NCT05384535 ·Status: RECRUITING ·Phase: NA
-
Pulse Sequence Development on 3T Magnetic Resonance Imaging/Spectroscopy
NCT00309504 ·Status: COMPLETED
-
Molecular PET/MR Imaging in Vivo Validation of Biomarker for Human Prostate Cancer
NCT03451812 ·Status: UNKNOWN
-
Imaging of Prostate Cancer Using Two-dimensional MR Spectroscopy and Diffusion Tensor Imaging
NCT00611065 ·Status: WITHDRAWN ·Phase: NA
-
Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer
NCT04692675 ·Status: RECRUITING ·Phase: NA
-
Imaging of High Grade Prostate Cancer
NCT02177526 ·Status: TERMINATED ·Phase: NA
-
Diagnostic Performance of 18F-PSMA-1007 PET/CT in Suspected Prostate Cancer Patient
NCT05422105 ·Status: UNKNOWN
-
3-Tesla MRI in Finding Tumors in Patients With Known or Suspected Prostate Cancer
NCT01653093 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Multifunctional Magnetic Resonance (MR) for Radiotherapy Planning in Prostate Cancer
NCT01006564 ·Status: UNKNOWN ·Phase: NA
-
Contrast Enhanced MRI of the Prostate
NCT02245282 ·Status: COMPLETED
-
Biological Imaging for Optimising Clinical Target Volume (CTV) and Gross Tumour Volume (GTV) Contouring in Prostate Cancer to Improve the Possibilities for Intensity Modulated RadioTherapy (IMRT) Dose Escalation
NCT00122252 ·Status: TERMINATED
-
Advanced Imaging for Radiotherapy Treatment Planning and Guidance for Low-Intermediate Risk Prostate Cancer (Margin)
NCT00890006 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Comparison of 5.0T and 3.0T Biparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer
NCT06612047 ·Status: RECRUITING
-
Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Diagnosing the Extent of Disease in Patients With Prostate Cancer
NCT00032058 ·Status: COMPLETED ·Phase: NA
-
3TMPO (Triple-Tracer Strategy Against Metastatic Prostate Cancer
NCT04000776 ·Status: COMPLETED
-
Predicting Prostate Biopsy Results With Biomarkers and mpMRI.
NCT03730324 ·Status: COMPLETED ·Phase: NA
-
Development of Magnetic Resonance (MR) Simulation for Treatment Planning
NCT00314496 ·Status: COMPLETED
-
Multi-parametric Magnetic Resonance Imaging for Prostate Cancer Patients
NCT03180398 ·Status: TERMINATED ·Phase: NA
-
18F-PSMA PET and MRI in the Primary Staging of Prostate Cancer Patients
NCT05141760 ·Status: COMPLETED ·Phase: PHASE2
-
PSMA-PET/CT Registry
NCT05709535 ·Status: TERMINATED
-
Characterize Tumor Hypoxia by Magnetic Resonance Imaging
NCT03987568 ·Status: WITHDRAWN ·Phase: NA
-
Magnetic Resonance Imaging and Spectroscopy of the Prostate
NCT00590993 ·Status: COMPLETED
-
Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy
NCT01834001 ·Status: RECRUITING
-
Advanced Magnetic Resonance Imaging (MRI) in Men With Suspected Prostate Cancer
NCT02745496 ·Status: COMPLETED ·Phase: NA